NCT03396198 is a clinical trial in Gastrointestinal Microbiome, sponsored by Mizu Jiang.

Who is sponsoring NCT03396198?

NCT03396198 is sponsored by Mizu Jiang.

What condition does NCT03396198 study?

NCT03396198 studies Gastrointestinal Microbiome.

Is NCT03396198 still recruiting?

NCT03396198 is currently status unknown. Last updated 2 July 2020.

Last reviewed 2020-07-02 · How we verify

NCT03396198

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Cohort Analysis Study of Intestinal Flora in Infants

Status unknown Last updated 2 July 2020

What this trial tests

trial in Gastrointestinal Microbiome in 100 participants. Status unknown.

Timeline

22 December 2017

Primary endpoint
22 June 2020

22 December 2020

Quick facts

Lead sponsor	Mizu Jiang
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	22 December 2017
Primary completion	22 June 2020
Estimated completion	22 December 2020
Sites	1 location across China

Conditions studied

Gastrointestinal Microbiome — all drugs for Gastrointestinal Microbiome →

Sponsor

Mizu Jiang

Who can join

Under 3, any sex, with Gastrointestinal Microbiome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the influence factors of gastrointestinal microbiome in infants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Role of the microbiome in human development.
Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. · · 2019 · cited 517× · PMID 30670574 · DOI 10.1136/gutjnl-2018-317503

Verify or expand the search:

Other recruiting trials for Gastrointestinal Microbiome

Currently open trials in the same condition.

NCT06802276 — Smart Underwear to Measure Diet-Induced Hydrogen Sulfide Production · NA · recruiting
NCT06207136 — Microbiome and Diet in Parkinson's Disease · NA · recruiting
NCT06359808 — Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis · recruiting
NCT05692024 — COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER · Phase 1, PHASE2 · recruiting
NCT05961189 — Influence of Short-Term Antibiotic Therapy on Exercise · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03396198 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mizu Jiang
Last refreshed: 2 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03396198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing